Definitive Healthcare Q2 Results: Earnings call set for Aug 10

1 min read | Published on 04 Aug 2026, 04:27 AM |Updated on 04 Aug 2026, 04:27 AM

Reviewed by

Anirudha BScanX News Team

Key Highlights

Definitive Healthcare Corp. will release its Q2 2026 earnings on August 10, 2026. The conference call is scheduled for 5:00 PM ET, with a replay available until September 9, 2026.

*this image is generated using AI for illustrative purposes only.

Definitive Healthcare Corp. (NASDAQ: DH) will report its second quarter 2026 financial results on Monday, August 10, 2026, after the market close. The healthcare market data and analytics company scheduled a conference call and webcast for 5:00 PM ET / 2:00 PM PT to discuss the quarterly performance with investors.

The live audio webcast will be available on the Definitive Healthcare Investor Relations website at ir.definitivehc.com. Investors can also dial in domestically at 877-358-7298 or internationally at +1-848-488-9244. A replay of the conference call will be accessible through September 9, 2026, at 800-645-7964 or 757-849-6722 using passcode 1765#.

Event Details

Detail	Information
Company	Definitive Healthcare Corp.
Quarter	Q2 ended June 30, 2026
Reporting Date	August 10, 2026 (After Market Close)
Call Time	5:00 PM ET / 2:00 PM PT
Webcast URL	ir.definitivehc.com
Replay Deadline	September 9, 2026

Definitive Healthcare focuses on providing data and analytics for the business side of healthcare, aiming to deliver insights that help organizations make strategic decisions. The company stated that its data helps cut through complexity in the healthcare market.

How might Definitive Healthcare's Q2 2026 revenue growth compare to the broader healthcare IT sector amid evolving data privacy regulations?

What impact could the company's latest analytics offerings have on its competitive positioning against rivals like IQVIA or Veracyte?

Will Definitive Healthcare adjust its full-year guidance based on Q2 performance, particularly regarding customer acquisition costs and churn rates?

B of A cuts Definitive Healthcare to Underperform, target $0.7

0 min read | Published on 29 Jun 2026, 05:45 PM |Updated on 29 Jun 2026, 05:45 PM

Reviewed by

Radhika SScanX News Team

Add as a preferred
source on Google

Key Highlights

B of A Securities analyst Allen Lutz downgraded Definitive Healthcare from Buy to Underperform and lowered the price target from $3.5 to $0.7, signaling a negative outlook for the NASDAQ-listed company.

*this image is generated using AI for illustrative purposes only.

B of A Securities analyst Allen Lutz has downgraded Definitive Healthcare from Buy to Underperform, significantly reducing the outlook for the stock. The firm lowered the price target to $0.7, down from the previous $3.5 target. This revision reflects a bearish shift in the analyst's perspective on the company's future performance.

The downgrade moves the stock from a Buy rating to Underperform, indicating that the analyst expects the shares to lag behind the broader market or industry averages. The substantial reduction in the price target suggests concerns over the company's ability to meet previous expectations.